Verition Fund Management’s Citius Pharmaceuticals CTXR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,352	Closed	-$101K	–	2033
2023 Q2	$101K	Buy	+3,352	New	+$101K	﹤0.01%	1695
2021 Q3	–	Sell	-2,103	Closed	-$183K	–	1719
2021 Q2	$183K	Buy	+2,103	New	+$183K	﹤0.01%	1481